Identification of the target self-antigens in reperfusion injury

Reperfusion injury (RI), a potential life-threatening disorder, represents an acute inflammatory response after periods of ischemia resulting from myocardial infarction, stroke, surgery, or trauma. The recent identification of a monoclonal natural IgM that initiates RI led to the identification of nonmuscle myosin heavy chain type II A and C as the self-targets in two different tissues. These results identify a novel pathway in which the innate response to a highly conserved self-antigen expressed as a result of hypoxic stress results in tissue destruction.

[1]  Yoshihiro Kawano,et al.  Novel multiwavelength microscopic scanner for mouse imaging. , 2005, Neoplasia.

[2]  Eric J. Brown,et al.  The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor , 2005, Nature.

[3]  Rodney K. Chan,et al.  Mast Cell Protease 5 Mediates Ischemia-Reperfusion Injury of Mouse Skeletal Muscle1 , 2005, The Journal of Immunology.

[4]  W. Reenstra,et al.  Gastrointestinal Ischemia-Reperfusion Injury Is Lectin Complement Pathway Dependent without Involving C1q 1 , 2005, The Journal of Immunology.

[5]  W. Silen,et al.  Present views on restitution of gastrointestinal epithelium , 1995, Digestive Diseases and Sciences.

[6]  V. Holers,et al.  Innate autoimmunity. , 2005, Advances in immunology.

[7]  Ryan P. Egan,et al.  Anti-Phospholipid Antibodies Restore Mesenteric Ischemia/Reperfusion-Induced Injury in Complement Receptor 2/Complement Receptor 1-Deficient Mice1 , 2004, The Journal of Immunology.

[8]  S. Fleming,et al.  Accelerated Ischemia/Reperfusion-Induced Injury in Autoimmunity-Prone Mice12 , 2004, The Journal of Immunology.

[9]  Rodney K. Chan,et al.  Murine hindlimb reperfusion injury can be initiated by a self-reactive monoclonal IgM. , 2004, Surgery.

[10]  B. Beutler,et al.  Inferences, questions and possibilities in Toll-like receptor signalling , 2004, Nature.

[11]  T. Fujita,et al.  The lectin‐complement pathway – its role in innate immunity and evolution , 2004, Immunological reviews.

[12]  S. Toda,et al.  Ischemic preconditioning attenuates ischemia-reperfusion-induced mucosal apoptosis by inhibiting the mitochondria-dependent pathway in rat small intestine. , 2004, American journal of physiology. Gastrointestinal and liver physiology.

[13]  H. Hechtman,et al.  Identification of a specific self-reactive IgM antibody that initiates intestinal ischemia/reperfusion injury. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[14]  L. Becker.  New concepts in reactive oxygen species and cardiovascular reperfusion physiology. , 2004, Cardiovascular research.

[15]  S. Hagl,et al.  Poly(ADP-ribose) polymerase activation in the reperfused myocardium. , 2004, Cardiovascular research.

[16]  Ehud Goldin,et al.  Identification and Characterization of Nonmuscle Myosin II-C, a New Member of the Myosin II Family* , 2004, Journal of Biological Chemistry.

[17]  C. Kocks,et al.  Functional Proteomics of the Active Cysteine Protease Content in Drosophila S2 Cells* , 2003, Molecular & Cellular Proteomics.

[18]  J. Nick,et al.  By Binding SIRPα or Calreticulin/CD91, Lung Collectins Act as Dual Function Surveillance Molecules to Suppress or Enhance Inflammation , 2003, Cell.

[19]  John D Lambris,et al.  C5a causes limited, polymorphonuclear cell-independent, mesenteric ischemia/reperfusion-induced injury. , 2003, Clinical immunology.

[20]  Timothy A. Springer,et al.  Structure and allosteric regulation of the αXβ2 integrin I domain , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[21]  M. Shimaoka,et al.  Structure and allosteric regulation of the alpha X beta 2 integrin I domain. , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[22]  L. Kobzik,et al.  Functional Activity of Natural Antibody is Altered in Cr2-Deficient Mice1 , 2002, The Journal of Immunology.

[23]  H. Ploegh,et al.  Chemistry-based functional proteomics reveals novel members of the deubiquitinating enzyme family. , 2002, Chemistry & biology.

[24]  M. Walport,et al.  Role of Surfactant Proteins A, D, and C1q in the Clearance of Apoptotic Cells In Vivo and In Vitro: Calreticulin and CD91 as a Common Collectin Receptor Complex1 , 2002, The Journal of Immunology.

[25]  J. Guthridge,et al.  Mice Deficient in Complement Receptors 1 and 2 Lack a Tissue Injury-Inducing Subset of the Natural Antibody Repertoire1 , 2002, The Journal of Immunology.

[26]  Hui Zhao,et al.  Murine model of gastrointestinal ischemia associated with complement-dependent injury. , 2002, Journal of applied physiology.

[27]  Z. Ding,et al.  Role of &agr;4 Integrin and VCAM-1 in CD18-Independent Neutrophil Migration Across Mouse Cardiac Endothelium , 2002, Circulation research.

[28]  R. Jackson,et al.  Reactive species mechanisms of cellular hypoxia-reoxygenation injury. , 2002, American journal of physiology. Cell physiology.

[29]  Marc Bonneville,et al.  Autoreactivity by design: innate B and T lymphocytes , 2001, Nature Reviews Immunology.

[30]  P. Hasselgren,et al.  Intestinal permeability is reduced and IL-10 levels are increased in septic IL-6 knockout mice. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.

[31]  J. Kearney,et al.  B1 cells: similarities and differences with other B cell subsets. , 2001, Current opinion in immunology.

[32]  Z. Ding,et al.  Leukocyte trafficking and myocardial reperfusion injury in ICAM-1/P-selectin-knockout mice. , 2001, American journal of physiology. Heart and circulatory physiology.

[33]  Steven J. Sollott,et al.  Reactive Oxygen Species (Ros-Induced) Ros Release , 2000, The Journal of experimental medicine.

[34]  P. Taylor,et al.  A Hierarchical Role for Classical Pathway Complement Proteins in the Clearance of Apoptotic Cells in Vivo , 2000, The Journal of experimental medicine.

[35]  M. Daemen,et al.  Evaluation of the membrane attack complex of complement for the detection of a recent myocardial infarction in man , 2000, The Journal of pathology.

[36]  S. Sanders,et al.  Soluble complement receptor-1 protects heart, lung, and cardiac myofilament function from cardiopulmonary bypass damage. , 2000, Circulation.

[37]  T. Vanden Hoek,et al.  Generation of superoxide in cardiomyocytes during ischemia before reperfusion. , 1999, American journal of physiology. Heart and circulatory physiology.

[38]  L. Kobzik,et al.  Intestinal ischemia-reperfusion injury is mediated by the membrane attack complex. , 1999, Surgery.

[39]  Yuan Zhang,et al.  Neuronal protection in stroke by an sLex-glycosylated complement inhibitory protein. , 1999, Science.

[40]  M. Weiser,et al.  Intestinal reperfusion injury is mediated by IgM and complement. , 1999, Journal of applied physiology.

[41]  A. Bresnick.  Molecular mechanisms of nonmuscle myosin-II regulation. , 1999, Current opinion in cell biology.

[42]  J. Kolega,et al.  Cytoplasmic dynamics of myosin IIA and IIB: spatial 'sorting' of isoforms in locomoting cells. , 1998, Journal of cell science.

[43]  B. Lucchesi,et al.  Attenuation of interleukin-8 expression in C6-deficient rabbits after myocardial ischemia/reperfusion. , 1998, Journal of molecular and cellular cardiology.

[44]  C. Thiemermann,et al.  Inhibition of the activity of poly(ADP ribose) synthetase reduces ischemia-reperfusion injury in the heart and skeletal muscle. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[45]  J. Schofer,et al.  Influence of the terminal complement-complex on reperfusion injury, no-reflow and arrhythmias: a comparison between C6-competent and C6-deficient rabbits. , 1996, Cardiovascular research.

[46]  J. Sellers,et al.  Xenopus nonmuscle myosin heavy chain isoforms have different subcellular localizations and enzymatic activities [published erratum appears in J Cell Biol 1997 Jul 14;138(1):215] , 1996, Journal of Cell Biology.

[47]  M. Weiser,et al.  Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement , 1996, The Journal of experimental medicine.

[48]  S. Clarke,et al.  Development of B-1 cells: segregation of phosphatidyl choline-specific B cells to the B-1 population occurs after immunoglobulin gene expression , 1994, The Journal of experimental medicine.

[49]  R. Hardy,et al.  Distinctive Developmental Origins and Specificities of Murine CD5+ B Cells , 1994, Immunological reviews.

[50]  L. Herzenberg,et al.  B-cell lineages exist in the mouse. , 1993, Immunology today.

[51]  T. Lindsay,et al.  Soluble complement receptor type 1 ameliorates the local and remote organ injury after intestinal ischemia-reperfusion in the rat. , 1992, Journal of immunology.

[52]  B. Lucchesi,et al.  Effects of complement activation in the isolated heart. Role of the terminal complement components. , 1992, Circulation research.

[53]  G. R. Carson,et al.  Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. , 1990, Science.

[54]  D. Pisetsky,et al.  The genetics of autoantibody production in MRL/lpr lupus mice. , 1989, Clinical and experimental rheumatology.

[55]  D. Mathey,et al.  Deposition of the terminal C5b-9 complement complex in infarcted areas of human myocardium. , 1986, Journal of immunology.

[56]  N. Niles.  Pathologic Basis of Disease , 1974 .

[57]  S. Robbins,et al.  Pathologic basis of disease , 1974 .

[58]  P. Ward,et al.  THE PHLOGISTIC ROLE OF C3 LEUKOTACTIC FRAGMENTS IN MYOCARDIAL INFARCTS OF RATS , 1971, The Journal of experimental medicine.

[59]  H. Scott,et al.  Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. , 1970, Archives of surgery.